mHealth may be valuable in treating chronic diseases, but standards, governance and integration still need work, says Robert Istepanian of the Institute of Global Innovation at the UK's Imperial College.
From left to right: HIMSS' Steve Wretling, Cornell's Dr. Joann Difede, Cedar-Sinai's Dr. Brennan Spiegel, Harvard and MGH's Dr. Anthony Sossong, and Rendever's Kyle Rand.
